Management includes eating smaller meals, avoiding trigger foods, remaining upright after eating, and using antacids or proton pump inhibitors if needed
Investment Opportunities For investors, the GLP-1 revolution presents multiple entry points beyond the pharmaceutical manufacturers themselves: Next-Generation Formulations : Several biotech companies are developing improved GLP-1 formulationsincluding oral versions, longer-lasting injectables, and combination therapies that address multiple metabolic pathways simultaneously
Due to their impact on both incretin systems, Dual GIP and GLP-1 agonists like tirzepatide (sold under brand names Mounjaro or Zepbound) are much more effective for weight loss
We invite you to schedule a consultation at our clinic to discuss whether GLP-1 medications might benefit your health situation
Wegovy is the cheapest GLP-1 available without insurance, costing $149 a month for the pill and $349 a month for the injectable